Prevalence and severity of cutaneous manifestations in patients of CRF on hemodialysis in relation to duration of replacement therapy
DOI:
https://doi.org/10.66344/jpad.31.2.2021.1764Abstract
Objective To determine the effect of duration of HD on the prevalence and severity of different cutaneous manifestations of ESRD. Methods 100 patients of ESRD at Fatima Memorial Hospital, Shadman were randomly enrolled and analyzed for multiple cutaneous manifestations over a period of eight months. The severity of these manifestations as mild, moderate, severe or very severe and their prevalence along with other particulars and time duration of HD was recorded in addition to any co-morbidities these patients had. Data was organized into tables and graphs. Results Out of 100 patients, 82% had xerosis, 69% had pruritus, 66% had pigmentary changes, 34% had nail changes, 15% had perforating dermatosis, 10% had bullous lesions, 30% had generalized hair loss and 7% had eczematization at the site of fistula. Out of 100 patients, 46% had severe xerosis, 19% had severe pruritus, 17% had severe pigmentary changes, 31% had severe nail changes, 14% had severe perforating dermatosis, no patients with bullous lesions fell in the category of severe disorder, 12% had severe hair loss and 4% had severe eczematization. The rest had mild and moderate forms of the disease. Conclusion Cutaneous manifestations among HD patients are common and most of them increase with an increase in the duration of HD. Coordination between a patient’s dermatologist and nephrologist can optimize their health experience.Downloads
Published
How to Cite
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.